Form 4: Prelude Therapeutics Executive Exercises Stock Options, Disposes of Shares for Tax Obligations
SEC Form 4
Jane Huang, President and CMO of Prelude Therapeutics, exercised stock options and disposed of shares to cover tax obligations on July 4, 2024.
Summary
- On July 4, 2024, Jane Huang, President and CMO of Prelude Therapeutics, exercised 9,375 Restricted Stock Units (RSUs).
- Following the exercise, Huang disposed of 3,347 shares of common stock to satisfy tax withholding obligations at a price of $3.6 per share.
- After these transactions, Huang directly owns 57,315 shares of common stock and 65,625 Restricted Stock Units.
- The RSUs were granted on May 2, 2022, and vest quarterly, subject to continued service.
Sentiment
Score: 5
Explanation: This is a neutral report on stock transactions related to executive compensation. It doesn't inherently indicate positive or negative sentiment about the company's performance.
Future Outlook
The RSUs continue to vest quarterly, contingent upon the reporting person's continued service to the Issuer.
Industry Context
This is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency into the transactions of company insiders.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they involve the exercise of existing stock options and do not represent a new issuance of shares, except for those issued upon RSU vesting.
Key Dates
| Date | Description |
|---|---|
| May 2, 2022 | Date the Restricted Stock Units were granted. |
| April 4, 2023 | Date when 1/4 of the total shares vested. |
| July 4, 2024 | Date of the reported transactions: RSU exercise and share disposal for tax obligations. |
| July 8, 2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.